Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

78 results about "Patient feedback" patented technology

Auto adjusting system for brain tissue stimulator

An implantable neurostimulator for treating disorders such as epilepsy, pain, movement disorders and depression includes a detection subsystem capable of detecting a physiological condition and a therapy subsystem capable of providing a course of therapy in response to the condition. The therapy subsystem includes an auto-adjust module for automatically adjusting one or more parameters of the therapy so that the therapy subsystem can provide an adjusted parameter to the patient and solicit the patient's feedback concerning the adjustment without requiring the presence of, or immediate involvement with, a clinician or physician. The patient feedback can be analyzed by computer, clinician or a combination of both to determine an optimal range of parameters for subsequent courses of therapy. In this manner, information useful in tuning the neurostimulator therapy parameters to optimize them for individual patient can be acquired automatically outside of the traditional clinical setting, saving time and minimizing patient fatigue that otherwise would be experience in marathon, in-clinic tuning sessions. The auto-adjust module also can be configured to prompt the patient to provide feedback even when parameters are not being adjusted, so as to acquire information for a baseline or about any placebo effect when the patient is otherwise expecting changes to the therapy to be made.
Owner:NEUROPACE

Auto adjusting system for brain tissue stimulator

An implantable neurostimulator for treating disorders such as epilepsy, pain, movement disorders and depression includes a detection subsystem capable of detecting a physiological condition and a therapy subsystem capable of providing a course of therapy in response to the condition. The therapy subsystem includes an auto-adjust module for automatically adjusting one or more parameters of the therapy so that the therapy subsystem can provide an adjusted parameter to the patient and solicit the patient's feedback concerning the adjustment without requiring the presence of, or immediate involvement with, a clinician or physician. The patient feedback can be analyzed by computer, clinician or a combination of both to determine an optimal range of parameters for subsequent courses of therapy. In this manner, information useful in tuning the neurostimulator therapy parameters to optimize them for individual patient can be acquired automatically outside of the traditional clinical setting, saving time and minimizing patient fatigue that otherwise would be experience in marathon, in-clinic tuning sessions. The auto-adjust module also can be configured to prompt the patient to provide feedback even when parameters are not being adjusted, so as to acquire information for a baseline or about any placebo effect when the patient is otherwise expecting changes to the therapy to be made.
Owner:NEUROPACE

Diabetes and cardiovascular and cerebrovascular disease monitoring and treatment system

InactiveCN103565521AReal-time monitoring of daily lifeMonitor daily lifeDiagnosticsSurgeryDisease monitoringData information
The invention provides a diabetes and cardiovascular and cerebrovascular disease monitoring and treatment system. The diabetes and cardiovascular and cerebrovascular disease monitoring and treatment system comprises a front-end monitoring system, an information middleware, an expert system and a center application system. The front-end monitoring system is connected with the center application system sequentially through the information middleware and the expert system, the front-end monitoring system sends data information to the information middleware and stores the data information into a database, the information middleware sends the data information to the expert system, and the expert system sends conclusions of the physical condition to the center application system. The diabetes and cardiovascular and cerebrovascular disease monitoring and treatment system can utilize low power consumption wireless communication technologies and sensing technologies to timely monitor physiological parameters, daily life, diet, exercise and medicine-taking time of a patient. A doctor can give patients feedbacks and advice by analyzing monitored data of the patients with chronic diseases and control the development of the diseases by supervising the implementation of the advice so as to improve the condition of the patients.
Owner:DIGICAN SHANGHAI CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products